Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy
Progestins, notably progesterone (P4) and 17 alpha hydroxyprogesterone caproate, are presently used to treat pregnant women at risk of preterm birth. The aim of this study was to assess the optimal treatment options for progesterone (P4) to delay delivery using a sensitive bioassay for progesterone.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 2017
|
| In: |
European journal of obstetrics & gynecology and reproductive biology
Year: 2017, Volume: 216, Pages: 164-168 |
| ISSN: | 1872-7654 |
| DOI: | 10.1016/j.ejogrb.2017.06.004 |
| Online Access: | Resolving-System, Volltext: http://dx.doi.org/10.1016/j.ejogrb.2017.06.004 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0301211517302786 
|
| Author Notes: | Dajun Fang, Mario Moreno, Robert E. Garfield, Ruben Kuon, Huimin Xia |
| Summary: | Progestins, notably progesterone (P4) and 17 alpha hydroxyprogesterone caproate, are presently used to treat pregnant women at risk of preterm birth. The aim of this study was to assess the optimal treatment options for progesterone (P4) to delay delivery using a sensitive bioassay for progesterone. |
|---|---|
| Item Description: | Gesehen am 20.11.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1872-7654 |
| DOI: | 10.1016/j.ejogrb.2017.06.004 |